Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Annovis Bio (ANVS)
NYSE:ANVS
Annovis Bio (ANVS) Stock Price & Analysis
252 Followers
ANVS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.39 - $23.91
Previous Close$19.6
Volume663.00
Average Volume (3M)55.06K
Market Cap
$153.10M
Enterprise Value$121.90M
Total Cash (Recent Filing)$31.99M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.7
Beta1.23
Next Earnings
Aug 08, 2022EPS Estimate
-$0.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.45
Shares Outstanding8,163,923
10 Day Avg. Volume45,482
30 Day Avg. Volume55,059
Standard Deviation0.40
R-Squared0.04
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)5.12
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-11.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.31
Forecast
1Y Price Target
$33.00Price Target Upside69.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Annovis Bio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANVS FAQ
What was Annovis Bio’s price range in the past 12 months?
Annovis Bio lowest stock price was $8.38 and its highest was $23.91 in the past 12 months.
What is Annovis Bio’s market cap?
Currently, no data Available
When is Annovis Bio’s upcoming earnings report date?
Annovis Bio’s upcoming earnings report date is Aug 08, 2022 which is 233 days ago.
How were Annovis Bio’s earnings last quarter?
Currently, no data Available
Is Annovis Bio overvalued?
According to Wall Street analysts Annovis Bio’s price is currently Undervalued.
Does Annovis Bio pay dividends?
Annovis Bio does not currently pay dividends.
What is Annovis Bio’s EPS estimate?
Annovis Bio’s EPS estimate is -$0.86.
How many shares outstanding does Annovis Bio have?
Annovis Bio has 8,163,923 shares outstanding.
What happened to Annovis Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Annovis Bio?
Currently, no hedge funds are holding shares in ANVS
---
Annovis Bio Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$33.00 (69.23% Upside)
$33.00 (69.23% Upside)
Insider Transactions
Bought Shares
Worth $7.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.37%
12-Months-Change
Fundamentals
Return on Equity
-73.60%
Trailing 12-Months
Asset Growth
-31.82%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Annovis Bio
Annovis Bio Inc is a United States based clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
---
Top 5 ETFs holding ANVS
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ANVS. The ETFs are listed according to market value of ANVS within the ETF
---
Senti Biosciences
―
Olema Pharmaceuticals
―
Candel Therapeutics
―
GlycoMimetics
―
Nuvectis Pharma
―
---